Business, energy, technology, markets and global industry news from Business News Today

PBGENE-DMD

PharmaDeviceNews PBGENE-DMD
Precision BioSciences’ leadership reshuffle puts PBGENE-HBV and PBGENE-DMD clinical execution in focus as the gene-editing company approaches key 2026 milestones. Representative image.
Pharma & Biotech

Precision BioSciences prepares leadership team for PBGENE-HBV and PBGENE-DMD data milestones

Precision BioSciences reshapes leadership to support PBGENE-HBV and PBGENE-DMD as two gene-editing trials approach key 2026 milestones.

Read More
Pharma & Biotech

Russell 2000 inclusion puts Precision BioSciences before more investors at a pivotal clinical stage

See how Russell 2000 inclusion expands Precision BioSciences’ investor reach while PBGENE-HBV and PBGENE-DMD face critical clinical tests.

Read More